reference/4412443

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/4412443

Outgoing Links

Predicate	Object
contentType	Clinical Trial, Phase II\|English Abstract\|Journal Article\|Multicenter Study\|Randomized Controlled Trial\|Research Support, Non-U.S. Gov't
endingPage	41
issn	0253-3766
issueIdentifier	2
pageRange	138-41
publicationName	Zhonghua zhong liu za zhi [Chinese journal of oncology]
startingPage	138
bibliographicCitation	Yang L, Wang JW, Sun Y, Zhu YZ, Liu XQ, Li WL, Di LJ, Li PW, Wang YL, Song SP, Yao C, You LF. [Randomized phase II trial on escalated doses of Rh-endostatin (YH-16) for advanced non-small cell lung cancer]. Zhonghua Zhong Liu Za Zhi. 2006 Feb;28(2):138–41. PMID: 16750022.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8b4c59f960a813562ecbc56901043049 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_29280c7364bd65c9a32eff9c38439b02 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8bfdbe698c3ba49525e2bdf9f99dfe2e http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c2b7baff9b0c1de4ee42617bb3604437 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_40a1dc249d97a26911eb10fe55be1925 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ccabf42ff624a0a0c93dadc2845f0286 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_750dfa3645891be6ea13095815341bf0 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c72609132dfed2cfe02784fb8340533a http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_10a647b206a92461f52a8311454acccf http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_16dff3f1721194032a38bce49aca6a03 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f749cfdca0d90dd1b6d4e4932dc98ecc http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ba032158b1118b08de30c0b22570ec82
date	200602
identifier	https://pubmed.ncbi.nlm.nih.gov/16750022
isPartOf	https://portal.issn.org/resource/ISSN/0253-3766 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/3435
language	Chinese
source	https://pubmed.ncbi.nlm.nih.gov/
title	[Randomized phase II trial on escalated doses of Rh-endostatin (YH-16) for advanced non-small cell lung cancer]
discusses	http://id.nlm.nih.gov/mesh/M0271306 http://id.nlm.nih.gov/mesh/M0018641 http://id.nlm.nih.gov/mesh/M0001483
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D043169Q000627 http://id.nlm.nih.gov/mesh/D000970Q000627 http://id.nlm.nih.gov/mesh/D008175Q000188 http://id.nlm.nih.gov/mesh/D002289Q000188
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D000970Q000008 http://id.nlm.nih.gov/mesh/D002289Q000473 http://id.nlm.nih.gov/mesh/D008875 http://id.nlm.nih.gov/mesh/D008297 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D000328 http://id.nlm.nih.gov/mesh/D011994Q000008 http://id.nlm.nih.gov/mesh/D004334 http://id.nlm.nih.gov/mesh/D008175Q000473 http://id.nlm.nih.gov/mesh/D011994Q000627 http://id.nlm.nih.gov/mesh/D012074 http://id.nlm.nih.gov/mesh/D018450 http://id.nlm.nih.gov/mesh/D000293 http://id.nlm.nih.gov/mesh/D043169Q000008 http://id.nlm.nih.gov/mesh/D004305 http://id.nlm.nih.gov/mesh/D009367 http://id.nlm.nih.gov/mesh/D011788 http://id.nlm.nih.gov/mesh/D005260 http://id.nlm.nih.gov/mesh/D000368
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_d0b1fec08786af63e5009a3fc1e18755 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7168 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID187888

Total number of triples: 57.